WNK2
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A6NKT7 | S980 | Sugiyama | RGPD3 RGP3 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSGAG |
| O14715 | S979 | Sugiyama | RGPD8 RANBP2ALPHA RANBP2L1 RANBP2L3 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSGAG |
| O43707 | S763 | Sugiyama | ACTN4 | IARTINEVENQILtRDAKGIsQEQMQEFRASFNHFDKDHGG |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O75821 | S28 | Sugiyama | EIF3G EIF3S4 | sKPsWADQVEEEGEDDKCVtsELLKGIPLAtGDtsPEPELL |
| P00558 | S393 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDA |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04083 | S170 | Sugiyama | ANXA1 ANX1 LPC1 | RDINRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsE |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05783 | S305 | Sugiyama | KRT18 CYK18 PIG46 | QSAEVGAAETTLTELRRtVQsLEIDLDsMRNLKAsLENsLR |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | S393 | Sugiyama | PGK2 PGKB | GGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEA |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07814 | S882 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | AQYKEKTGKEyIPGQPPLsQssDssPtRNsEPAGLEtPEAK |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T85 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LDsGKELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtI |
| P08238 | T94 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSGtKAFM |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08670 | S325 | Sugiyama | VIM | NNDALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMR |
| P08758 | T8 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | _____________MAQVLRGtVtDFPGFDERADAEtLRKAM |
| P0DJD0 | S964 | Sugiyama | RGPD1 RANBP2L6 RGP1 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDPNFKGFSGAG |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | S58 | Sugiyama | H1-4 H1F4 HIST1H1E | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P13667 | T380 | Sugiyama | PDIA4 ERP70 ERP72 | PEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGHR |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14618 | S55 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | IDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMNVARLN |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S172 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSELI |
| P14625 | S551 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKEKQDKIyFMAGsSRKEAEssPFVERLLKKGyEVIyLTEP |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | S59 | Sugiyama | H1-3 H1F3 HIST1H1D | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S58 | Sugiyama | H1-2 H1F2 HIST1H1C | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P18124 | T17 | Sugiyama | RPL7 | ____MEGVEEKKKEVPAVPEtLKKKRRNFAELKIKRLRKKF |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22626 | S344 | Sugiyama | HNRNPA2B1 HNRPA2B1 | sRNMGGPyGGGNyGPGGsGGsGGyGGRsRy___________ |
| P25398 | S107 | Sugiyama | RPS12 | EWVGLCKIDREGKPRKVVGCsCVVVKDYGKESQAKDVIEEy |
| P25789 | T10 | Sugiyama | PSMA4 HC9 PSC9 | ___________MSRRyDsRttIFsPEGRLYQVEYAMEAIGH |
| P26232 | S667 | Sugiyama | CTNNA2 CAPR | YDVRsRtsVQtEDDQLIAGQsARAIMAQLPQEEKAKIAEQV |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P29323 | Y596 | Sugiyama | EPHB2 DRT EPHT3 EPTH3 ERK HEK5 TYRO5 | EytDKLQHytsGHMTPGMKIyIDPFtyEDPNEAVREFAKEI |
| P29323 | Y602 | Sugiyama | EPHB2 DRT EPHT3 EPTH3 ERK HEK5 TYRO5 | QHytsGHMTPGMKIyIDPFtyEDPNEAVREFAKEIDISCVK |
| P29401 | S443 | Sugiyama | TKT | EDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAAN |
| P29401 | T444 | Sugiyama | TKT | DGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANT |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P29692 | S65 | Sugiyama | EEF1D EF1D | VILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRIA |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P31327 | T45 | Sugiyama | CPS1 | AHQKWKFSRPGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPS |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P35221 | S668 | Sugiyama | CTNNA1 | FDVRsRtsVQtEDDQLIAGQsARAIMAQLPQEQKAKIAEQV |
| P35579 | S1916 | Sugiyama | MYH9 | LQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMAR |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T111 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAFtADGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDP |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P46013 | S651 | Sugiyama | MKI67 | ISRsQHDILQMICSKRRsGAsEANLIVAKSWADVVKLGAKQ |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46777 | T177 | Sugiyama | RPL5 MSTP030 | NKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHRK |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P47712 | S729 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | KEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKPKA |
| P47914 | S142 | Sugiyama | RPL29 | KAKAKAKAKDQTKAQAAAPAsVPAQAPKRtQAPtKAsE___ |
| P48643 | S270 | Sugiyama | CCT5 CCTE KIAA0098 | ILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQ |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P49368 | T254 | Sugiyama | CCT3 CCTG TRIC5 | KNPRIVLLDssLEyKKGEsQtDIEITREEDFTRILQMEEEY |
| P49792 | S1955 | Sugiyama | RANBP2 NUP358 | GVIFGQTSSTFTFADLAKstsGEGFQFGKKDPNFKGFSGAG |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P54762 | Y594 | Sugiyama | EPHB1 ELK EPHT2 HEK6 NET | VYSDKLQHYSTGRGsPGMKIyIDPFtyEDPNEAVREFAKEI |
| P54762 | Y600 | Sugiyama | EPHB1 ELK EPHT2 HEK6 NET | QHYSTGRGsPGMKIyIDPFtyEDPNEAVREFAKEIDVSFVK |
| P60174 | S106 | Sugiyama | TPI1 TPI | DCGAtWVVLGHsERRHVFGEsDELIGQKVAHALAEGLGVIA |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | T304 | Sugiyama | ACTB | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61081 | S175 | Sugiyama | UBE2M UBC12 | NNRRLFEQNVQRSMRGGyIGstyFERCLK____________ |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | T146 | Sugiyama | RPL8 | LARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANRAVV |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63220 | S65 | Sugiyama | RPS21 | RFNGQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF__ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | T304 | Sugiyama | ACTG1 ACTG | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q12965 | S980 | Sugiyama | MYO1E MYO1C | GyHQNGVIRNQyVPYPHAPGsQRSNQKSLyTsMARPPLPRQ |
| Q13283 | S67 | Sugiyama | G3BP1 G3BP | sNGKPADAVyGQKEIHRKVMsQNFtNCHTKIRHVDAHATLN |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15185 | S82 | Sugiyama | PTGES3 P23 TEBP | NDsKHKRtDRsILCCLRKGEsGQsWPRLTKERAKLNWLsVD |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q5SSJ5 | S323 | Sugiyama | HP1BP3 | NALQRAVERGQLEQITGKGAsGTFQLKKSGEKPLLGGSLME |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q6PCE3 | S175 | Sugiyama | PGM2L1 BM32A | PFVPYAVQKLKAVAGVMItAsHNRKEDNGYKVYWETGAQIT |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7Z3J3 | S980 | Sugiyama | RGPD4 RGP4 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDPNFKGFSGAG |
| Q86V81 | S145 | Sugiyama | ALYREF ALY BEF THOC4 | LFAEFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQ |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q99666 | S979 | Sugiyama | RGPD5 RANBP2L1 RGP5 RGP7 RGPD7; RGPD6 RANBP2L2 RGP6 | GVIFGQTSSTFTFADVAKstsGEGFQFGKKDLNFKGFSGAG |
| Q99832 | S59 | Sugiyama | CCT7 CCTH NIP7-1 | TLGPRGMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAKTL |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BYP7 | S289 | Sugiyama | WNK3 KIAA1566 PRKWNK3 | PPIIHRDLKCDNIFItGPtGsVKIGDLGLATLMRtsFAKsV |
| Q9BYP7 | T284 | Sugiyama | WNK3 KIAA1566 PRKWNK3 | LHTRTPPIIHRDLKCDNIFItGPtGsVKIGDLGLATLMRts |
| Q9BYP7 | T287 | Sugiyama | WNK3 KIAA1566 PRKWNK3 | RTPPIIHRDLKCDNIFItGPtGsVKIGDLGLATLMRtsFAK |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9H173 | T125 | Sugiyama | SIL1 UNQ545/PRO836 | QYEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAEME |
| Q9H4A3 | S2372 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | QPVGTASLQNFNISNLQKsIsNPPGSNLRTT__________ |
| Q9H4A3 | S363 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | PPIIHRDLKCDNIFItGPtGsVKIGDLGLATLKRAsFAKsV |
| Q9H4A3 | S382 | SIGNOR|EPSD|PSP | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GsVKIGDLGLATLKRAsFAKsVIGtPEFMAPEMYEEKYDES |
| Q9H4A3 | T358 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | LHTRTPPIIHRDLKCDNIFItGPtGsVKIGDLGLATLKRAs |
| Q9H4A3 | T361 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | RTPPIIHRDLKCDNIFItGPtGsVKIGDLGLATLKRAsFAK |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9UEW8 | S371 | EPSD|PSP | STK39 PASK SPAK | LtRtPDIAQRAKKVRRVPGssGHLHKTEDGDWEWsDDEMDE |
| Q9UEW8 | T354 | EPSD|PSP | STK39 PASK SPAK | CKFFQKAKNREYLIEKLLtRtPDIAQRAKKVRRVPGssGHL |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y3S1 | S337 | Sugiyama | WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 | PPIIHRDLKCDNIFItGPtGsVKIGDLGLATLKRAsFAKSV |
| Q9Y3S1 | S472 | Sugiyama | WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 | FFAEDTGVRVELAEEDHGRKstIALRLWVEDPKKLKGKPKD |
| Q9Y3S1 | T332 | Sugiyama | WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 | LHTRTPPIIHRDLKCDNIFItGPtGsVKIGDLGLATLKRAs |
| Q9Y3S1 | T335 | Sugiyama | WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 | RTPPIIHRDLKCDNIFItGPtGsVKIGDLGLATLKRAsFAK |
| Q9Y3S1 | T473 | Sugiyama | WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 | FAEDTGVRVELAEEDHGRKstIALRLWVEDPKKLKGKPKDN |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.440892e-16 | 15.353 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.881784e-16 | 15.051 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.881784e-16 | 15.051 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.554312e-15 | 14.808 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.107825e-15 | 14.386 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.107026e-15 | 14.292 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 9.658940e-15 | 14.015 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 9.547918e-15 | 14.020 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.252953e-14 | 13.488 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.852474e-14 | 13.414 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.296740e-13 | 12.887 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.960166e-13 | 12.402 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.759837e-13 | 12.240 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 7.004397e-13 | 12.155 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.020517e-12 | 11.991 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.663003e-12 | 11.779 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.841638e-12 | 11.735 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.993072e-12 | 11.700 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.130518e-12 | 11.672 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.306555e-12 | 11.366 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.398371e-12 | 11.357 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.305645e-12 | 11.275 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.270007e-12 | 11.278 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.036882e-11 | 10.984 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.271017e-11 | 10.644 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.550049e-11 | 10.450 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.776624e-11 | 10.321 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.111167e-11 | 10.214 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.491552e-11 | 10.188 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 6.786705e-11 | 10.168 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.900069e-11 | 10.161 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.280898e-11 | 10.138 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.194234e-11 | 10.143 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.678780e-11 | 10.115 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.043410e-11 | 10.095 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.285828e-11 | 10.032 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.004925e-10 | 9.998 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.004925e-10 | 9.998 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.074223e-10 | 9.969 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.474872e-10 | 9.831 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.974551e-10 | 9.705 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.068249e-10 | 9.684 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.671334e-10 | 9.573 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.457253e-10 | 9.461 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.849334e-10 | 9.415 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.493401e-10 | 9.347 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.780425e-10 | 9.238 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 6.968290e-10 | 9.157 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.619072e-10 | 9.065 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.941325e-10 | 9.049 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.746547e-10 | 9.011 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.287600e-09 | 8.890 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.287600e-09 | 8.890 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.932692e-09 | 8.714 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.989409e-09 | 8.524 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.563957e-09 | 8.448 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.003698e-09 | 8.398 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.575127e-09 | 8.340 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.680657e-09 | 8.330 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.504121e-09 | 8.187 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.223997e-09 | 8.141 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 8.280370e-09 | 8.082 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.379966e-09 | 8.077 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 9.170201e-09 | 8.038 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.208944e-08 | 7.918 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.463439e-08 | 7.608 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.475350e-08 | 7.606 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.706173e-08 | 7.568 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.688423e-08 | 7.433 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.963840e-08 | 7.402 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.173319e-08 | 7.380 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.329892e-08 | 7.364 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.096828e-08 | 7.215 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.920203e-08 | 7.160 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.304849e-08 | 7.136 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 7.738256e-08 | 7.111 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 9.456290e-08 | 7.024 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.822424e-08 | 7.008 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.293050e-07 | 6.888 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.376923e-07 | 6.861 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.945050e-07 | 6.711 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.174566e-07 | 6.663 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.505176e-07 | 6.601 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.236473e-07 | 6.490 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.317292e-07 | 6.479 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.496605e-07 | 6.456 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.580492e-07 | 6.446 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.223738e-07 | 6.374 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.223738e-07 | 6.374 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 4.344484e-07 | 6.362 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.554144e-07 | 6.255 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.719246e-07 | 6.243 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.053688e-07 | 6.218 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.436220e-07 | 6.191 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.234275e-07 | 6.084 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.234275e-07 | 6.084 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.234275e-07 | 6.084 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.234275e-07 | 6.084 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.995100e-07 | 6.097 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 8.836016e-07 | 6.054 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.943073e-07 | 6.049 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.964801e-07 | 6.047 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.964801e-07 | 6.047 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.591610e-07 | 6.018 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.025492e-06 | 5.989 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.038253e-06 | 5.984 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.202965e-06 | 5.920 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.556916e-06 | 5.808 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.703345e-06 | 5.769 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.788864e-06 | 5.747 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.790285e-06 | 5.747 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.203649e-06 | 5.657 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.151920e-06 | 5.501 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.732361e-06 | 5.428 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.755452e-06 | 5.425 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.995463e-06 | 5.398 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.153302e-06 | 5.382 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.318836e-06 | 5.365 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.566283e-06 | 5.340 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.766479e-06 | 5.322 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.322306e-06 | 5.274 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 5.441312e-06 | 5.264 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.110670e-06 | 5.214 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.564345e-06 | 5.183 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 7.095864e-06 | 5.149 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.135530e-06 | 5.147 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.236882e-06 | 5.084 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 9.303309e-06 | 5.031 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.127507e-05 | 4.948 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.209801e-05 | 4.917 | 0 | 0 |
| Translation | R-HSA-72766 | 1.336152e-05 | 4.874 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.340602e-05 | 4.873 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.502357e-05 | 4.823 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.429310e-05 | 4.845 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.436568e-05 | 4.843 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.510735e-05 | 4.821 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.554856e-05 | 4.808 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.587205e-05 | 4.799 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.770017e-05 | 4.752 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.905283e-05 | 4.720 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.960751e-05 | 4.708 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.072495e-05 | 4.684 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.181481e-05 | 4.661 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.181481e-05 | 4.661 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.181481e-05 | 4.661 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.181481e-05 | 4.661 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.181481e-05 | 4.661 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.060437e-05 | 4.686 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.060437e-05 | 4.686 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.181481e-05 | 4.661 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.514066e-05 | 4.600 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.824187e-05 | 4.549 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.919328e-05 | 4.535 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.060542e-05 | 4.514 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.169303e-05 | 4.499 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.406062e-05 | 4.468 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.496140e-05 | 4.456 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.345147e-05 | 4.362 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.720243e-05 | 4.326 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.739129e-05 | 4.324 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.878899e-05 | 4.312 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.111486e-05 | 4.291 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.195188e-05 | 4.284 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.243087e-05 | 4.280 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.436491e-05 | 4.265 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.542672e-05 | 4.256 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.683805e-05 | 4.245 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.732846e-05 | 4.242 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 6.298885e-05 | 4.201 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.286839e-05 | 4.137 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 7.422803e-05 | 4.129 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.505334e-05 | 4.125 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 8.019688e-05 | 4.096 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 8.034838e-05 | 4.095 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.263333e-05 | 4.083 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.341922e-05 | 4.079 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 8.742537e-05 | 4.058 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 8.742537e-05 | 4.058 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.122891e-05 | 4.040 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 9.156205e-05 | 4.038 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.391237e-05 | 4.027 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 9.889866e-05 | 4.005 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 9.993151e-05 | 4.000 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.018424e-04 | 3.992 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.165132e-04 | 3.934 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.163766e-04 | 3.934 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.163700e-04 | 3.934 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.258547e-04 | 3.900 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.301827e-04 | 3.885 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.495678e-04 | 3.825 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.577954e-04 | 3.802 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.646164e-04 | 3.784 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.652323e-04 | 3.782 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.655054e-04 | 3.781 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.655054e-04 | 3.781 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.690097e-04 | 3.772 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.734995e-04 | 3.761 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.735954e-04 | 3.760 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.981615e-04 | 3.703 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.881799e-04 | 3.725 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.905412e-04 | 3.720 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.903173e-04 | 3.721 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.981615e-04 | 3.703 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.943527e-04 | 3.711 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.981615e-04 | 3.703 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.055299e-04 | 3.687 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.175426e-04 | 3.662 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.193599e-04 | 3.659 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.346454e-04 | 3.630 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.452331e-04 | 3.610 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.658604e-04 | 3.575 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.719215e-04 | 3.566 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.723664e-04 | 3.565 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.781705e-04 | 3.556 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.900596e-04 | 3.538 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.949602e-04 | 3.530 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.026205e-04 | 3.519 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.041447e-04 | 3.517 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.053314e-04 | 3.515 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.066771e-04 | 3.513 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 3.105060e-04 | 3.508 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.324814e-04 | 3.478 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.104487e-04 | 3.508 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.166281e-04 | 3.499 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.518031e-04 | 3.454 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.518031e-04 | 3.454 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.522684e-04 | 3.453 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.518031e-04 | 3.454 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.166281e-04 | 3.499 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.522684e-04 | 3.453 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.899761e-04 | 3.409 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.927008e-04 | 3.406 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.061204e-04 | 3.391 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.062368e-04 | 3.391 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.223829e-04 | 3.374 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 4.311213e-04 | 3.365 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.382491e-04 | 3.358 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.475164e-04 | 3.349 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.530518e-04 | 3.344 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.638452e-04 | 3.334 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.708968e-04 | 3.327 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.830641e-04 | 3.316 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.901948e-04 | 3.310 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.951138e-04 | 3.305 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.039484e-04 | 3.298 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.250857e-04 | 3.280 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.316204e-04 | 3.274 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.762621e-04 | 3.239 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.762621e-04 | 3.239 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.899218e-04 | 3.229 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 6.535433e-04 | 3.185 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.701144e-04 | 3.174 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.845171e-04 | 3.165 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.845171e-04 | 3.165 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.845171e-04 | 3.165 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 7.708178e-04 | 3.113 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 8.162813e-04 | 3.088 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.500635e-04 | 3.125 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.500635e-04 | 3.125 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.526761e-04 | 3.123 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.093749e-04 | 3.149 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.093749e-04 | 3.149 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 8.162813e-04 | 3.088 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.924957e-04 | 3.101 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 8.430703e-04 | 3.074 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.493255e-04 | 3.071 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.507374e-04 | 3.070 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 8.507374e-04 | 3.070 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.589024e-04 | 3.066 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.595649e-04 | 3.066 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 8.655497e-04 | 3.063 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.940746e-04 | 3.049 | 0 | 0 |
| S Phase | R-HSA-69242 | 9.022443e-04 | 3.045 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 9.489410e-04 | 3.023 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.489410e-04 | 3.023 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 9.655581e-04 | 3.015 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 9.739768e-04 | 3.011 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 9.807304e-04 | 3.008 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.002995e-03 | 2.999 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.031153e-03 | 2.987 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.031153e-03 | 2.987 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.033818e-03 | 2.986 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.071044e-03 | 2.970 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.103410e-03 | 2.957 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.103410e-03 | 2.957 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.103410e-03 | 2.957 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.103410e-03 | 2.957 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.143303e-03 | 2.942 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.158268e-03 | 2.936 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.231115e-03 | 2.910 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.235227e-03 | 2.908 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.235227e-03 | 2.908 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.255170e-03 | 2.901 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.285521e-03 | 2.891 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.360103e-03 | 2.866 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.412709e-03 | 2.850 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.431889e-03 | 2.844 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.434378e-03 | 2.843 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.579176e-03 | 2.802 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.511076e-03 | 2.821 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.499980e-03 | 2.824 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.463098e-03 | 2.835 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.495542e-03 | 2.825 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.579176e-03 | 2.802 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.531864e-03 | 2.815 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.518003e-03 | 2.819 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.518003e-03 | 2.819 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.638956e-03 | 2.785 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.731060e-03 | 2.762 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.734141e-03 | 2.761 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.744261e-03 | 2.758 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.788033e-03 | 2.748 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.812849e-03 | 2.742 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.825996e-03 | 2.739 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.836708e-03 | 2.736 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.855748e-03 | 2.731 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.859100e-03 | 2.731 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.922099e-03 | 2.716 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.931709e-03 | 2.714 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.092131e-03 | 2.679 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.092131e-03 | 2.679 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.121197e-03 | 2.673 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.121197e-03 | 2.673 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.164988e-03 | 2.665 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.216549e-03 | 2.654 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.218823e-03 | 2.654 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.309406e-03 | 2.636 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.311822e-03 | 2.636 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.370594e-03 | 2.625 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.413684e-03 | 2.617 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.504797e-03 | 2.601 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.504797e-03 | 2.601 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.664663e-03 | 2.574 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.665760e-03 | 2.574 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.058513e-03 | 2.514 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.065343e-03 | 2.514 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.065343e-03 | 2.514 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.182005e-03 | 2.497 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.182005e-03 | 2.497 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.182005e-03 | 2.497 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.247657e-03 | 2.488 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.253070e-03 | 2.488 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.257461e-03 | 2.487 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.257461e-03 | 2.487 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.277227e-03 | 2.484 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.277227e-03 | 2.484 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.305949e-03 | 2.481 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.305949e-03 | 2.481 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.331558e-03 | 2.477 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.367015e-03 | 2.473 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 3.367015e-03 | 2.473 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 3.446508e-03 | 2.463 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.803689e-03 | 2.420 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 4.020654e-03 | 2.396 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.795864e-03 | 2.421 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.795864e-03 | 2.421 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.951745e-03 | 2.403 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.017165e-03 | 2.396 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.356544e-03 | 2.361 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.951745e-03 | 2.403 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.951745e-03 | 2.403 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.951745e-03 | 2.403 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.803689e-03 | 2.420 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.894027e-03 | 2.410 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.010421e-03 | 2.397 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.669103e-03 | 2.435 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 3.950535e-03 | 2.403 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.352197e-03 | 2.361 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.845803e-03 | 2.415 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.329337e-03 | 2.364 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.795864e-03 | 2.421 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.928821e-03 | 2.406 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.771556e-03 | 2.423 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.418009e-03 | 2.355 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.464923e-03 | 2.350 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.464923e-03 | 2.350 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.464923e-03 | 2.350 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.471958e-03 | 2.350 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.499482e-03 | 2.347 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.500148e-03 | 2.347 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.621911e-03 | 2.335 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.652501e-03 | 2.332 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.754480e-03 | 2.323 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.754480e-03 | 2.323 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.754480e-03 | 2.323 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 4.761000e-03 | 2.322 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 4.761000e-03 | 2.322 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.037995e-03 | 2.298 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.080375e-03 | 2.294 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.133207e-03 | 2.290 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.248620e-03 | 2.280 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.307574e-03 | 2.275 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.771160e-03 | 2.239 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 5.771160e-03 | 2.239 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 5.813151e-03 | 2.236 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 5.813151e-03 | 2.236 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.045885e-03 | 2.219 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.045885e-03 | 2.219 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 6.140012e-03 | 2.212 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.189281e-03 | 2.208 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.189281e-03 | 2.208 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 6.533915e-03 | 2.185 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 6.533915e-03 | 2.185 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 6.533915e-03 | 2.185 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 6.533915e-03 | 2.185 | 0 | 0 |
| Immune System | R-HSA-168256 | 6.568522e-03 | 2.183 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.641657e-03 | 2.178 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 6.774335e-03 | 2.169 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 6.774335e-03 | 2.169 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.774335e-03 | 2.169 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 6.774335e-03 | 2.169 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 6.774335e-03 | 2.169 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 6.777341e-03 | 2.169 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 6.992066e-03 | 2.155 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.992066e-03 | 2.155 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.992066e-03 | 2.155 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.083707e-03 | 2.150 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.083707e-03 | 2.150 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 7.128401e-03 | 2.147 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.178294e-03 | 2.144 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.818474e-03 | 2.107 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.010243e-03 | 2.096 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.012374e-03 | 2.096 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.012374e-03 | 2.096 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.253668e-03 | 2.083 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.351423e-03 | 2.078 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.351423e-03 | 2.078 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.351423e-03 | 2.078 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 8.365237e-03 | 2.078 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.365237e-03 | 2.078 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.375040e-03 | 2.077 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.606322e-03 | 2.065 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.606322e-03 | 2.065 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.777415e-03 | 2.057 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.845936e-03 | 2.053 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.845936e-03 | 2.053 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.845936e-03 | 2.053 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.866407e-03 | 2.052 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 8.866407e-03 | 2.052 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.866407e-03 | 2.052 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.909078e-03 | 2.050 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 9.418119e-03 | 2.026 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 9.418119e-03 | 2.026 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.418119e-03 | 2.026 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.418119e-03 | 2.026 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 9.468097e-03 | 2.024 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 9.468097e-03 | 2.024 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 9.630816e-03 | 2.016 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.298298e-02 | 1.887 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.151286e-02 | 1.939 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.249909e-02 | 1.903 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.028991e-02 | 1.988 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 9.908853e-03 | 2.004 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.029267e-02 | 1.987 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.189260e-02 | 1.925 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.099200e-02 | 1.959 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.153580e-02 | 1.938 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.226134e-02 | 1.911 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.882161e-03 | 2.005 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.049056e-02 | 1.979 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.151286e-02 | 1.939 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.223450e-02 | 1.912 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.267269e-02 | 1.897 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.168238e-02 | 1.932 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.298298e-02 | 1.887 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.139448e-02 | 1.943 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.151286e-02 | 1.939 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.226134e-02 | 1.911 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.012034e-02 | 1.995 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.908853e-03 | 2.004 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.168238e-02 | 1.932 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.226134e-02 | 1.911 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.226134e-02 | 1.911 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.176779e-02 | 1.929 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.186990e-02 | 1.926 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.882161e-03 | 2.005 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.051789e-02 | 1.978 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.310245e-02 | 1.883 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.310245e-02 | 1.883 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.367952e-02 | 1.864 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.377930e-02 | 1.861 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.434543e-02 | 1.843 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.450758e-02 | 1.838 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.475524e-02 | 1.831 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.475524e-02 | 1.831 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.475524e-02 | 1.831 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.475524e-02 | 1.831 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.475524e-02 | 1.831 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.475524e-02 | 1.831 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.475524e-02 | 1.831 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.475524e-02 | 1.831 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.475524e-02 | 1.831 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.475524e-02 | 1.831 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.475524e-02 | 1.831 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.475524e-02 | 1.831 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.475524e-02 | 1.831 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.475524e-02 | 1.831 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 1.481194e-02 | 1.829 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.483310e-02 | 1.829 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.483310e-02 | 1.829 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.517964e-02 | 1.819 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.517964e-02 | 1.819 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 1.517964e-02 | 1.819 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.517964e-02 | 1.819 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.529598e-02 | 1.815 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.545954e-02 | 1.811 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.556657e-02 | 1.808 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.559156e-02 | 1.807 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.559156e-02 | 1.807 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.559156e-02 | 1.807 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.566685e-02 | 1.805 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.625739e-02 | 1.789 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.629443e-02 | 1.788 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.673046e-02 | 1.776 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.696441e-02 | 1.770 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.700618e-02 | 1.769 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.705056e-02 | 1.768 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.705056e-02 | 1.768 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.705383e-02 | 1.768 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.714845e-02 | 1.766 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.724110e-02 | 1.763 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.724110e-02 | 1.763 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.803803e-02 | 1.744 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.848254e-02 | 1.733 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.848254e-02 | 1.733 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.867612e-02 | 1.729 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.878411e-02 | 1.726 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.878411e-02 | 1.726 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.891250e-02 | 1.723 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.901866e-02 | 1.721 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.914469e-02 | 1.718 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.924598e-02 | 1.716 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.924598e-02 | 1.716 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 1.954365e-02 | 1.709 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.957640e-02 | 1.708 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.957640e-02 | 1.708 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.957640e-02 | 1.708 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.029663e-02 | 1.693 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.127393e-02 | 1.672 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.130333e-02 | 1.672 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 2.130333e-02 | 1.672 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.327377e-02 | 1.633 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.327377e-02 | 1.633 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.327377e-02 | 1.633 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 2.443097e-02 | 1.612 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.493971e-02 | 1.603 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.493971e-02 | 1.603 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.540103e-02 | 1.595 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.597127e-02 | 1.586 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.597127e-02 | 1.586 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 2.597127e-02 | 1.586 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.616048e-02 | 1.582 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.629217e-02 | 1.580 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 2.629217e-02 | 1.580 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.629217e-02 | 1.580 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.632129e-02 | 1.580 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.697840e-02 | 1.569 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.697840e-02 | 1.569 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.697840e-02 | 1.569 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.697840e-02 | 1.569 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.697840e-02 | 1.569 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.754967e-02 | 1.560 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.799137e-02 | 1.553 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.799137e-02 | 1.553 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.811418e-02 | 1.551 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 2.844109e-02 | 1.546 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.844109e-02 | 1.546 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.844109e-02 | 1.546 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.848423e-02 | 1.545 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.865309e-02 | 1.543 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.878635e-02 | 1.541 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.878635e-02 | 1.541 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.893951e-02 | 1.539 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.897782e-02 | 1.538 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.897782e-02 | 1.538 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.061542e-02 | 1.514 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.111994e-02 | 1.507 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.142374e-02 | 1.503 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.148411e-02 | 1.502 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.167484e-02 | 1.499 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.167484e-02 | 1.499 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.253623e-02 | 1.488 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.297843e-02 | 1.482 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.415695e-02 | 1.467 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 3.492832e-02 | 1.457 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.492832e-02 | 1.457 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.492832e-02 | 1.457 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.492832e-02 | 1.457 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.147673e-02 | 1.382 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.147673e-02 | 1.382 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.147673e-02 | 1.382 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.147673e-02 | 1.382 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.147673e-02 | 1.382 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.939361e-02 | 1.405 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.939361e-02 | 1.405 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.240310e-02 | 1.281 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 5.240310e-02 | 1.281 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 5.240310e-02 | 1.281 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 5.240310e-02 | 1.281 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.550477e-02 | 1.450 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.550477e-02 | 1.450 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.550477e-02 | 1.450 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.360636e-02 | 1.360 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.932511e-02 | 1.405 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.599749e-02 | 1.337 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.599749e-02 | 1.337 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.644165e-02 | 1.438 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.219303e-02 | 1.375 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.992861e-02 | 1.302 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.570449e-02 | 1.447 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.324401e-02 | 1.364 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.773782e-02 | 1.423 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.951331e-02 | 1.403 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.147673e-02 | 1.382 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.147673e-02 | 1.382 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.360636e-02 | 1.360 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.847679e-02 | 1.415 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.039273e-02 | 1.298 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.852536e-02 | 1.314 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.852536e-02 | 1.314 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.515513e-02 | 1.345 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.489595e-02 | 1.348 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 4.732277e-02 | 1.325 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 3.570449e-02 | 1.447 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.741152e-02 | 1.324 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.644165e-02 | 1.438 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.932511e-02 | 1.405 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.984580e-02 | 1.302 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.939361e-02 | 1.405 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.704497e-02 | 1.327 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 4.669389e-02 | 1.331 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.034232e-02 | 1.394 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.395004e-02 | 1.357 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.240310e-02 | 1.281 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.850189e-02 | 1.314 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.219921e-02 | 1.375 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.610632e-02 | 1.442 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.702636e-02 | 1.431 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.240310e-02 | 1.281 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.599749e-02 | 1.337 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.610632e-02 | 1.442 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.741152e-02 | 1.324 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.052377e-02 | 1.392 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.034232e-02 | 1.394 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 5.240310e-02 | 1.281 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.277695e-02 | 1.278 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.315137e-02 | 1.274 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.531925e-02 | 1.257 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 5.593156e-02 | 1.252 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 5.593156e-02 | 1.252 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 5.593156e-02 | 1.252 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 5.593156e-02 | 1.252 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 5.593156e-02 | 1.252 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 5.593156e-02 | 1.252 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.625304e-02 | 1.250 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.642668e-02 | 1.249 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.642668e-02 | 1.249 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.661650e-02 | 1.247 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.754794e-02 | 1.240 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 5.832470e-02 | 1.234 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 5.832470e-02 | 1.234 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.982372e-02 | 1.223 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.982372e-02 | 1.223 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.016845e-02 | 1.221 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 6.016845e-02 | 1.221 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.016845e-02 | 1.221 | 0 | 0 |
| IRS activation | R-HSA-74713 | 6.016845e-02 | 1.221 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 6.016845e-02 | 1.221 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 6.145898e-02 | 1.211 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.299695e-02 | 1.201 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.299695e-02 | 1.201 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.299695e-02 | 1.201 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.303476e-02 | 1.200 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.303476e-02 | 1.200 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.303476e-02 | 1.200 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.317344e-02 | 1.199 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 6.317344e-02 | 1.199 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.345582e-02 | 1.198 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.670979e-02 | 1.176 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.670979e-02 | 1.176 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.733329e-02 | 1.172 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.746833e-02 | 1.171 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 6.746833e-02 | 1.171 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 6.746833e-02 | 1.171 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 6.746833e-02 | 1.171 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.746833e-02 | 1.171 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.746833e-02 | 1.171 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.785026e-02 | 1.168 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.785026e-02 | 1.168 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.027519e-02 | 1.153 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.027519e-02 | 1.153 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.027519e-02 | 1.153 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.027519e-02 | 1.153 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.159672e-02 | 1.145 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.250888e-02 | 1.140 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.303225e-02 | 1.136 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.438517e-02 | 1.129 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.438517e-02 | 1.129 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.438517e-02 | 1.129 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.438517e-02 | 1.129 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.590495e-02 | 1.120 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 7.772193e-02 | 1.109 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.825456e-02 | 1.106 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.825456e-02 | 1.106 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.914001e-02 | 1.102 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.982427e-02 | 1.098 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.982427e-02 | 1.098 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.982427e-02 | 1.098 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.982427e-02 | 1.098 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.994841e-02 | 1.097 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.994841e-02 | 1.097 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.994841e-02 | 1.097 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.998760e-02 | 1.097 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.045754e-02 | 1.094 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.045754e-02 | 1.094 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.210391e-02 | 1.086 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.210391e-02 | 1.086 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 8.210391e-02 | 1.086 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 8.210391e-02 | 1.086 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 8.210391e-02 | 1.086 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.210391e-02 | 1.086 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.331923e-02 | 1.079 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.331923e-02 | 1.079 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 8.331923e-02 | 1.079 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.331923e-02 | 1.079 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 8.452205e-02 | 1.073 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 8.452205e-02 | 1.073 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.572354e-02 | 1.067 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.682103e-02 | 1.061 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.780432e-02 | 1.056 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.780432e-02 | 1.056 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 9.010642e-02 | 1.045 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.010642e-02 | 1.045 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.010642e-02 | 1.045 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 9.010642e-02 | 1.045 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.117117e-02 | 1.040 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.117117e-02 | 1.040 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 9.170508e-02 | 1.038 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 9.170508e-02 | 1.038 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.386097e-02 | 1.028 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 9.559287e-02 | 1.020 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.559287e-02 | 1.020 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.559287e-02 | 1.020 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 9.559287e-02 | 1.020 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 9.559287e-02 | 1.020 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.559287e-02 | 1.020 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.570492e-02 | 1.019 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.799756e-02 | 1.009 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.799756e-02 | 1.009 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.003087e-01 | 0.999 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.003232e-01 | 0.999 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.003232e-01 | 0.999 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.011165e-01 | 0.995 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.011165e-01 | 0.995 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 1.016811e-01 | 0.993 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.034588e-01 | 0.985 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.034588e-01 | 0.985 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.034588e-01 | 0.985 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.034588e-01 | 0.985 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.051447e-01 | 0.978 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 1.069402e-01 | 0.971 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 1.069402e-01 | 0.971 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.069402e-01 | 0.971 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 1.069402e-01 | 0.971 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.186088e-01 | 0.926 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.186088e-01 | 0.926 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.186088e-01 | 0.926 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.186088e-01 | 0.926 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.186088e-01 | 0.926 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.186088e-01 | 0.926 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.186088e-01 | 0.926 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.186088e-01 | 0.926 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 1.186088e-01 | 0.926 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.186088e-01 | 0.926 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.186088e-01 | 0.926 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.186088e-01 | 0.926 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.186088e-01 | 0.926 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.186088e-01 | 0.926 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.186088e-01 | 0.926 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.186088e-01 | 0.926 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.186088e-01 | 0.926 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.186088e-01 | 0.926 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.186088e-01 | 0.926 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.186088e-01 | 0.926 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.186088e-01 | 0.926 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.186088e-01 | 0.926 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.186088e-01 | 0.926 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.186088e-01 | 0.926 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.186088e-01 | 0.926 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.186088e-01 | 0.926 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.186088e-01 | 0.926 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.186088e-01 | 0.926 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.186088e-01 | 0.926 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.186088e-01 | 0.926 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.186088e-01 | 0.926 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.186088e-01 | 0.926 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 1.186088e-01 | 0.926 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.186088e-01 | 0.926 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.186088e-01 | 0.926 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.322753e-01 | 0.879 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 1.322753e-01 | 0.879 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.322753e-01 | 0.879 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.760023e-01 | 0.754 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.760023e-01 | 0.754 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 1.760023e-01 | 0.754 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.760023e-01 | 0.754 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.342885e-01 | 0.872 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.342885e-01 | 0.872 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 1.342885e-01 | 0.872 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.342885e-01 | 0.872 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.342885e-01 | 0.872 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 1.342885e-01 | 0.872 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.637393e-01 | 0.786 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 1.637393e-01 | 0.786 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 1.637393e-01 | 0.786 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.637393e-01 | 0.786 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.637393e-01 | 0.786 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.241426e-01 | 0.906 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.241426e-01 | 0.906 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.241426e-01 | 0.906 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.120620e-01 | 0.951 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.464139e-01 | 0.834 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.464139e-01 | 0.834 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.464139e-01 | 0.834 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.464139e-01 | 0.834 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.464139e-01 | 0.834 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.464139e-01 | 0.834 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.464139e-01 | 0.834 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.948815e-01 | 0.710 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.948815e-01 | 0.710 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.948815e-01 | 0.710 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.948815e-01 | 0.710 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.948815e-01 | 0.710 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 1.948815e-01 | 0.710 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 1.948815e-01 | 0.710 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.297948e-01 | 0.887 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.297948e-01 | 0.887 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.700963e-01 | 0.769 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.700963e-01 | 0.769 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.700963e-01 | 0.769 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.148615e-01 | 0.940 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.148615e-01 | 0.940 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.487071e-01 | 0.828 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.950028e-01 | 0.710 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.950028e-01 | 0.710 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.950028e-01 | 0.710 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.950028e-01 | 0.710 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.687033e-01 | 0.773 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.687033e-01 | 0.773 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.468749e-01 | 0.833 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.284928e-01 | 0.891 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.284928e-01 | 0.891 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.284928e-01 | 0.891 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.584673e-01 | 0.800 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.115228e-01 | 0.675 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.745448e-01 | 0.758 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.013777e-01 | 0.696 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.013777e-01 | 0.696 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.173521e-01 | 0.931 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.102216e-01 | 0.958 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.763235e-01 | 0.754 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.620249e-01 | 0.790 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.456916e-01 | 0.837 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.140844e-01 | 0.943 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.763235e-01 | 0.754 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.241426e-01 | 0.906 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.148615e-01 | 0.940 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.234477e-01 | 0.909 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.080067e-01 | 0.682 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 1.342885e-01 | 0.872 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.950028e-01 | 0.710 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.146753e-01 | 0.941 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.241393e-01 | 0.906 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.035261e-01 | 0.691 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.760023e-01 | 0.754 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.700963e-01 | 0.769 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.896789e-01 | 0.722 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.584673e-01 | 0.800 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.013777e-01 | 0.696 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.810744e-01 | 0.742 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.904994e-01 | 0.720 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 1.464139e-01 | 0.834 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.352017e-01 | 0.869 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.297948e-01 | 0.887 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 2.140495e-01 | 0.669 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.948815e-01 | 0.710 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.950028e-01 | 0.710 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.722743e-01 | 0.764 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.554767e-01 | 0.808 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.467842e-01 | 0.833 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.380494e-01 | 0.860 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.554767e-01 | 0.808 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.554767e-01 | 0.808 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.534829e-01 | 0.814 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.997960e-01 | 0.699 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.719362e-01 | 0.765 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.982822e-01 | 0.703 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.423913e-01 | 0.847 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.896137e-01 | 0.722 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.102216e-01 | 0.958 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.760023e-01 | 0.754 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.760023e-01 | 0.754 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.760023e-01 | 0.754 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.464139e-01 | 0.834 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.431025e-01 | 0.844 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.190650e-01 | 0.924 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.694617e-01 | 0.771 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.299282e-01 | 0.886 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.244955e-01 | 0.905 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.815500e-01 | 0.741 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.342885e-01 | 0.872 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 1.904994e-01 | 0.720 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.881831e-01 | 0.725 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.120620e-01 | 0.951 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.730435e-01 | 0.762 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.303832e-01 | 0.885 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.700963e-01 | 0.769 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.464139e-01 | 0.834 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.464139e-01 | 0.834 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 1.128443e-01 | 0.948 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.381220e-01 | 0.860 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.950028e-01 | 0.710 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 1.730398e-01 | 0.762 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.201705e-01 | 0.920 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.917449e-01 | 0.717 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.259062e-01 | 0.900 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 2.051688e-01 | 0.688 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.464139e-01 | 0.834 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.464139e-01 | 0.834 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.332325e-01 | 0.875 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.971057e-01 | 0.705 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.131832e-01 | 0.671 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.128443e-01 | 0.948 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.115228e-01 | 0.675 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.635876e-01 | 0.786 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.863493e-01 | 0.730 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.863493e-01 | 0.730 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 2.115228e-01 | 0.675 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.146883e-01 | 0.668 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.155656e-01 | 0.666 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 2.159256e-01 | 0.666 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.180620e-01 | 0.661 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.209407e-01 | 0.656 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.209407e-01 | 0.656 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.209407e-01 | 0.656 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.210002e-01 | 0.656 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.210002e-01 | 0.656 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.210002e-01 | 0.656 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.215674e-01 | 0.654 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.215674e-01 | 0.654 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.215674e-01 | 0.654 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.215674e-01 | 0.654 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.215674e-01 | 0.654 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.215674e-01 | 0.654 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 2.215674e-01 | 0.654 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.231430e-01 | 0.651 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 2.231556e-01 | 0.651 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.231556e-01 | 0.651 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.231556e-01 | 0.651 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.231556e-01 | 0.651 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.231556e-01 | 0.651 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 2.231556e-01 | 0.651 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 2.231556e-01 | 0.651 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 2.231556e-01 | 0.651 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 2.231556e-01 | 0.651 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 2.231556e-01 | 0.651 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 2.231556e-01 | 0.651 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.231556e-01 | 0.651 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 2.231556e-01 | 0.651 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.231556e-01 | 0.651 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.231556e-01 | 0.651 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.231556e-01 | 0.651 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.231556e-01 | 0.651 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.264614e-01 | 0.645 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.265649e-01 | 0.645 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.265649e-01 | 0.645 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.265649e-01 | 0.645 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.265649e-01 | 0.645 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.265649e-01 | 0.645 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.273158e-01 | 0.643 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 2.273158e-01 | 0.643 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.273158e-01 | 0.643 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.273158e-01 | 0.643 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.273158e-01 | 0.643 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 2.273158e-01 | 0.643 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 2.273158e-01 | 0.643 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.273158e-01 | 0.643 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.297414e-01 | 0.639 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 2.297414e-01 | 0.639 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.303129e-01 | 0.638 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.313638e-01 | 0.636 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 2.313638e-01 | 0.636 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 2.317470e-01 | 0.635 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.341197e-01 | 0.631 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.341197e-01 | 0.631 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.341197e-01 | 0.631 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.341197e-01 | 0.631 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.341197e-01 | 0.631 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.412230e-01 | 0.618 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.449876e-01 | 0.611 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.467368e-01 | 0.608 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.467368e-01 | 0.608 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.471903e-01 | 0.607 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 2.477166e-01 | 0.606 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.477166e-01 | 0.606 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.477166e-01 | 0.606 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.477166e-01 | 0.606 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.549573e-01 | 0.594 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.551232e-01 | 0.593 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.554383e-01 | 0.593 | 0 | 0 |
| Disease | R-HSA-1643685 | 2.568431e-01 | 0.590 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.573520e-01 | 0.589 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.573520e-01 | 0.589 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.573520e-01 | 0.589 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.606647e-01 | 0.584 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 2.606647e-01 | 0.584 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.606647e-01 | 0.584 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.606647e-01 | 0.584 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.606647e-01 | 0.584 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.606647e-01 | 0.584 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.606647e-01 | 0.584 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.638555e-01 | 0.579 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.679201e-01 | 0.572 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 2.679201e-01 | 0.572 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.679201e-01 | 0.572 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.679201e-01 | 0.572 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.679201e-01 | 0.572 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 2.679201e-01 | 0.572 | 0 | 0 |
| Proton/oligopeptide cotransporters | R-HSA-427975 | 2.679201e-01 | 0.572 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.679201e-01 | 0.572 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.679201e-01 | 0.572 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.751398e-01 | 0.560 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.751398e-01 | 0.560 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 2.751398e-01 | 0.560 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.751398e-01 | 0.560 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.751398e-01 | 0.560 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 2.751398e-01 | 0.560 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 2.773989e-01 | 0.557 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.811015e-01 | 0.551 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 2.812228e-01 | 0.551 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.818583e-01 | 0.550 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 2.818583e-01 | 0.550 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.818583e-01 | 0.550 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 2.818583e-01 | 0.550 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.831087e-01 | 0.548 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.831476e-01 | 0.548 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.944890e-01 | 0.531 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.945783e-01 | 0.531 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.945783e-01 | 0.531 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 2.945783e-01 | 0.531 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.945783e-01 | 0.531 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.945783e-01 | 0.531 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 2.945783e-01 | 0.531 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.945783e-01 | 0.531 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.946168e-01 | 0.531 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 3.030259e-01 | 0.519 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 3.030259e-01 | 0.519 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 3.030259e-01 | 0.519 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.040372e-01 | 0.517 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 3.052515e-01 | 0.515 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.052515e-01 | 0.515 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.052515e-01 | 0.515 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.142329e-01 | 0.503 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.142329e-01 | 0.503 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.142329e-01 | 0.503 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.142329e-01 | 0.503 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.142329e-01 | 0.503 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.142329e-01 | 0.503 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.145757e-01 | 0.502 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.153069e-01 | 0.501 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.153069e-01 | 0.501 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.153069e-01 | 0.501 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.153069e-01 | 0.501 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.153069e-01 | 0.501 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 3.153069e-01 | 0.501 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.153069e-01 | 0.501 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.153069e-01 | 0.501 | 0 | 0 |
| Beta-ketothiolase deficiency | R-HSA-9915355 | 3.153069e-01 | 0.501 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.153069e-01 | 0.501 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 3.153069e-01 | 0.501 | 0 | 0 |
| Mitochondrial short-chain enoyl-CoA hydratase deficiency 1 | R-HSA-9916720 | 3.153069e-01 | 0.501 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 3.153069e-01 | 0.501 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.153069e-01 | 0.501 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.153069e-01 | 0.501 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.153069e-01 | 0.501 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.153069e-01 | 0.501 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.153069e-01 | 0.501 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.153069e-01 | 0.501 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.153069e-01 | 0.501 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 3.153069e-01 | 0.501 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.153069e-01 | 0.501 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.181759e-01 | 0.497 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.181759e-01 | 0.497 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.207548e-01 | 0.494 | 1 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.257296e-01 | 0.487 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.257296e-01 | 0.487 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.265014e-01 | 0.486 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.287385e-01 | 0.483 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 3.287385e-01 | 0.483 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 3.287385e-01 | 0.483 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 3.287385e-01 | 0.483 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.287385e-01 | 0.483 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 3.287385e-01 | 0.483 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.287385e-01 | 0.483 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.296878e-01 | 0.482 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 3.296878e-01 | 0.482 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.296878e-01 | 0.482 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 3.311987e-01 | 0.480 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.311987e-01 | 0.480 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.379095e-01 | 0.471 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.415274e-01 | 0.467 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.482453e-01 | 0.458 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.485133e-01 | 0.458 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.500384e-01 | 0.456 | 1 | 1 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.506599e-01 | 0.455 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.543003e-01 | 0.451 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 3.543003e-01 | 0.451 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.553108e-01 | 0.449 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 3.553108e-01 | 0.449 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.594928e-01 | 0.444 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 3.594928e-01 | 0.444 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 3.594928e-01 | 0.444 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.594928e-01 | 0.444 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.594928e-01 | 0.444 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 3.594928e-01 | 0.444 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.598635e-01 | 0.444 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.598635e-01 | 0.444 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.598635e-01 | 0.444 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.598635e-01 | 0.444 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.598635e-01 | 0.444 | 0 | 0 |
| SLC-mediated transport of oligopeptides | R-HSA-9959399 | 3.598635e-01 | 0.444 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.602464e-01 | 0.443 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.602464e-01 | 0.443 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.627636e-01 | 0.440 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.627636e-01 | 0.440 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.628609e-01 | 0.440 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 3.628609e-01 | 0.440 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.628609e-01 | 0.440 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.706447e-01 | 0.431 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.718572e-01 | 0.430 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.740674e-01 | 0.427 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.789835e-01 | 0.421 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.789835e-01 | 0.421 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.801152e-01 | 0.420 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.830398e-01 | 0.417 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.830398e-01 | 0.417 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.830398e-01 | 0.417 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 3.833405e-01 | 0.416 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.877542e-01 | 0.411 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.877542e-01 | 0.411 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.877542e-01 | 0.411 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.877542e-01 | 0.411 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.877542e-01 | 0.411 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 3.877542e-01 | 0.411 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 3.911430e-01 | 0.408 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.928212e-01 | 0.406 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.928890e-01 | 0.406 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.928890e-01 | 0.406 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.943815e-01 | 0.404 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.954628e-01 | 0.403 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.954628e-01 | 0.403 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.965317e-01 | 0.402 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.965317e-01 | 0.402 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 3.965317e-01 | 0.402 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.965317e-01 | 0.402 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 3.965317e-01 | 0.402 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.965317e-01 | 0.402 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.965317e-01 | 0.402 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.965317e-01 | 0.402 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 3.965317e-01 | 0.402 | 0 | 0 |
| Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization | R-HSA-180897 | 3.965317e-01 | 0.402 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.965317e-01 | 0.402 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.965317e-01 | 0.402 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.965317e-01 | 0.402 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.965317e-01 | 0.402 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.965317e-01 | 0.402 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.966953e-01 | 0.402 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.966953e-01 | 0.402 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 3.966953e-01 | 0.402 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 3.966953e-01 | 0.402 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.036378e-01 | 0.394 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.036378e-01 | 0.394 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.036378e-01 | 0.394 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 4.043223e-01 | 0.393 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.043223e-01 | 0.393 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.043223e-01 | 0.393 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.043223e-01 | 0.393 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.043223e-01 | 0.393 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 4.043223e-01 | 0.393 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.043223e-01 | 0.393 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.043223e-01 | 0.393 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.105777e-01 | 0.387 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.117312e-01 | 0.385 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 4.149716e-01 | 0.382 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 4.149716e-01 | 0.382 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.149716e-01 | 0.382 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.158420e-01 | 0.381 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 4.158420e-01 | 0.381 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.175973e-01 | 0.379 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.244721e-01 | 0.372 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.244721e-01 | 0.372 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.249505e-01 | 0.372 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.249505e-01 | 0.372 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.249505e-01 | 0.372 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 4.281701e-01 | 0.368 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 4.300250e-01 | 0.367 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 4.300250e-01 | 0.367 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 4.300250e-01 | 0.367 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.300250e-01 | 0.367 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.305512e-01 | 0.366 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.438351e-01 | 0.353 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.453112e-01 | 0.351 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.472454e-01 | 0.349 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 4.472454e-01 | 0.349 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.472454e-01 | 0.349 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.472454e-01 | 0.349 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.472454e-01 | 0.349 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.472454e-01 | 0.349 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.472454e-01 | 0.349 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.472454e-01 | 0.349 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 4.472454e-01 | 0.349 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.472454e-01 | 0.349 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.472454e-01 | 0.349 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.472454e-01 | 0.349 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 4.472454e-01 | 0.349 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.472454e-01 | 0.349 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.472454e-01 | 0.349 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.589282e-01 | 0.338 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 4.626656e-01 | 0.335 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.626656e-01 | 0.335 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.626656e-01 | 0.335 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 4.626656e-01 | 0.335 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.681250e-01 | 0.330 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.681250e-01 | 0.330 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.681250e-01 | 0.330 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 4.681250e-01 | 0.330 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.681250e-01 | 0.330 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.709991e-01 | 0.327 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 4.709991e-01 | 0.327 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.709991e-01 | 0.327 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 4.709991e-01 | 0.327 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 4.765294e-01 | 0.322 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 4.790343e-01 | 0.320 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.838274e-01 | 0.315 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.883716e-01 | 0.311 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.883716e-01 | 0.311 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.883716e-01 | 0.311 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.883716e-01 | 0.311 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.883716e-01 | 0.311 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 4.944632e-01 | 0.306 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.944632e-01 | 0.306 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.944632e-01 | 0.306 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.944632e-01 | 0.306 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 4.978534e-01 | 0.303 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.020244e-01 | 0.299 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 5.059451e-01 | 0.296 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.229944e-01 | 0.282 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 5.231160e-01 | 0.281 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.234560e-01 | 0.281 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 5.241036e-01 | 0.281 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 5.241036e-01 | 0.281 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 5.241494e-01 | 0.281 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.252920e-01 | 0.280 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.252920e-01 | 0.280 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.252920e-01 | 0.280 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.252920e-01 | 0.280 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.252920e-01 | 0.280 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.275232e-01 | 0.278 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 5.275232e-01 | 0.278 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.275232e-01 | 0.278 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.275232e-01 | 0.278 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 5.275232e-01 | 0.278 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 5.277340e-01 | 0.278 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.312285e-01 | 0.275 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.312285e-01 | 0.275 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.312285e-01 | 0.275 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.312285e-01 | 0.275 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.312285e-01 | 0.275 | 0 | 0 |
| Defective FMO3 causes TMAU | R-HSA-5579019 | 5.312285e-01 | 0.275 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.312285e-01 | 0.275 | 0 | 0 |
| GABA synthesis | R-HSA-888568 | 5.312285e-01 | 0.275 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.312285e-01 | 0.275 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.312285e-01 | 0.275 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.312285e-01 | 0.275 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.380217e-01 | 0.269 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.438410e-01 | 0.265 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.462248e-01 | 0.263 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.496747e-01 | 0.260 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.550520e-01 | 0.256 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.550520e-01 | 0.256 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 5.550520e-01 | 0.256 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 5.550520e-01 | 0.256 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.550520e-01 | 0.256 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 5.550520e-01 | 0.256 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.550520e-01 | 0.256 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.641587e-01 | 0.249 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.645900e-01 | 0.248 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 5.645900e-01 | 0.248 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.645900e-01 | 0.248 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 5.645900e-01 | 0.248 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 5.645900e-01 | 0.248 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 5.645900e-01 | 0.248 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.684610e-01 | 0.245 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.684610e-01 | 0.245 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.692809e-01 | 0.245 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.745038e-01 | 0.241 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 5.794072e-01 | 0.237 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.799463e-01 | 0.237 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.836666e-01 | 0.234 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.836666e-01 | 0.234 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.836666e-01 | 0.234 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.857374e-01 | 0.232 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.868483e-01 | 0.231 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.868483e-01 | 0.231 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 5.868483e-01 | 0.231 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.868483e-01 | 0.231 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.868483e-01 | 0.231 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.868483e-01 | 0.231 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.868483e-01 | 0.231 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.868483e-01 | 0.231 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.868483e-01 | 0.231 | 0 | 0 |
| Hydroxycarboxylic acid-binding receptors | R-HSA-3296197 | 5.868483e-01 | 0.231 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.868483e-01 | 0.231 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.868483e-01 | 0.231 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.868483e-01 | 0.231 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.868483e-01 | 0.231 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 5.874149e-01 | 0.231 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 5.874149e-01 | 0.231 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 5.888238e-01 | 0.230 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.901214e-01 | 0.229 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 5.985395e-01 | 0.223 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.995154e-01 | 0.222 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.995154e-01 | 0.222 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.995154e-01 | 0.222 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.995154e-01 | 0.222 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.995154e-01 | 0.222 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.995154e-01 | 0.222 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.995154e-01 | 0.222 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.995154e-01 | 0.222 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.995154e-01 | 0.222 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.995154e-01 | 0.222 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 6.008111e-01 | 0.221 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.110801e-01 | 0.214 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.110801e-01 | 0.214 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.110801e-01 | 0.214 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.110801e-01 | 0.214 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.156184e-01 | 0.211 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 6.217408e-01 | 0.206 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.217408e-01 | 0.206 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.217408e-01 | 0.206 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.257457e-01 | 0.204 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.257457e-01 | 0.204 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.257457e-01 | 0.204 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.257457e-01 | 0.204 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.257457e-01 | 0.204 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 6.257457e-01 | 0.204 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 6.301448e-01 | 0.201 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.315744e-01 | 0.200 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.315744e-01 | 0.200 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.315744e-01 | 0.200 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 6.315744e-01 | 0.200 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.322857e-01 | 0.199 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 6.322857e-01 | 0.199 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.322857e-01 | 0.199 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.324157e-01 | 0.199 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.349021e-01 | 0.197 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.358717e-01 | 0.197 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.358717e-01 | 0.197 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.358717e-01 | 0.197 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.358717e-01 | 0.197 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.358717e-01 | 0.197 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.358717e-01 | 0.197 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.358717e-01 | 0.197 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.358717e-01 | 0.197 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.358717e-01 | 0.197 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.358717e-01 | 0.197 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.358717e-01 | 0.197 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 6.358717e-01 | 0.197 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.358717e-01 | 0.197 | 0 | 0 |
| Threonine catabolism | R-HSA-8849175 | 6.358717e-01 | 0.197 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.358717e-01 | 0.197 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 6.358717e-01 | 0.197 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.358717e-01 | 0.197 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 6.358717e-01 | 0.197 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 6.358717e-01 | 0.197 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.358717e-01 | 0.197 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.358717e-01 | 0.197 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 6.358717e-01 | 0.197 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.372552e-01 | 0.196 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 6.372552e-01 | 0.196 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.372552e-01 | 0.196 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 6.403626e-01 | 0.194 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.513125e-01 | 0.186 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.585227e-01 | 0.181 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.598673e-01 | 0.181 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 6.621709e-01 | 0.179 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.629207e-01 | 0.179 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 6.629207e-01 | 0.179 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.629207e-01 | 0.179 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.629207e-01 | 0.179 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 6.703647e-01 | 0.174 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.757873e-01 | 0.170 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 6.757873e-01 | 0.170 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.790807e-01 | 0.168 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.790807e-01 | 0.168 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.790807e-01 | 0.168 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.790807e-01 | 0.168 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.790807e-01 | 0.168 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.790807e-01 | 0.168 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.790807e-01 | 0.168 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.790807e-01 | 0.168 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 6.790807e-01 | 0.168 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.790807e-01 | 0.168 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.790807e-01 | 0.168 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 6.790807e-01 | 0.168 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.790807e-01 | 0.168 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.858200e-01 | 0.164 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.880920e-01 | 0.162 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.880920e-01 | 0.162 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.880920e-01 | 0.162 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.914656e-01 | 0.160 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 6.914656e-01 | 0.160 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 6.914656e-01 | 0.160 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 6.960696e-01 | 0.157 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.057117e-01 | 0.151 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.082074e-01 | 0.150 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.082074e-01 | 0.150 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.082074e-01 | 0.150 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.116772e-01 | 0.148 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 7.171645e-01 | 0.144 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 7.171645e-01 | 0.144 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 7.171645e-01 | 0.144 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.171645e-01 | 0.144 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.171645e-01 | 0.144 | 0 | 0 |
| Opsins | R-HSA-419771 | 7.171645e-01 | 0.144 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 7.171645e-01 | 0.144 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.171645e-01 | 0.144 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.171645e-01 | 0.144 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 7.171645e-01 | 0.144 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 7.171645e-01 | 0.144 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.171645e-01 | 0.144 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.179850e-01 | 0.144 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.179850e-01 | 0.144 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.179850e-01 | 0.144 | 0 | 0 |
| Mineralocorticoid biosynthesis | R-HSA-193993 | 7.179850e-01 | 0.144 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.179850e-01 | 0.144 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.179850e-01 | 0.144 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.179850e-01 | 0.144 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 7.179850e-01 | 0.144 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.201358e-01 | 0.143 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.244431e-01 | 0.140 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.244431e-01 | 0.140 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.244431e-01 | 0.140 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.293480e-01 | 0.137 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.293480e-01 | 0.137 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 7.293480e-01 | 0.137 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.293480e-01 | 0.137 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.384556e-01 | 0.132 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.390573e-01 | 0.131 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.399503e-01 | 0.131 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.422721e-01 | 0.129 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.422721e-01 | 0.129 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 7.425576e-01 | 0.129 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 7.425576e-01 | 0.129 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 7.425576e-01 | 0.129 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 7.425576e-01 | 0.129 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 7.425576e-01 | 0.129 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.492653e-01 | 0.125 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.492653e-01 | 0.125 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.492653e-01 | 0.125 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.507308e-01 | 0.125 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.507308e-01 | 0.125 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.507308e-01 | 0.125 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.507308e-01 | 0.125 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.507308e-01 | 0.125 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.507308e-01 | 0.125 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.507308e-01 | 0.125 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.507308e-01 | 0.125 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.507308e-01 | 0.125 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.507308e-01 | 0.125 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.507308e-01 | 0.125 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.507308e-01 | 0.125 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.534086e-01 | 0.123 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.550294e-01 | 0.122 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 7.578344e-01 | 0.120 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.592096e-01 | 0.120 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.592096e-01 | 0.120 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.652719e-01 | 0.116 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.652719e-01 | 0.116 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.652719e-01 | 0.116 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.662193e-01 | 0.116 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.672877e-01 | 0.115 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.679895e-01 | 0.115 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.679895e-01 | 0.115 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.679895e-01 | 0.115 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.752706e-01 | 0.111 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 7.758506e-01 | 0.110 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.796971e-01 | 0.108 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.803153e-01 | 0.108 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.803153e-01 | 0.108 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.803153e-01 | 0.108 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.803153e-01 | 0.108 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.803153e-01 | 0.108 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.803153e-01 | 0.108 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.803625e-01 | 0.108 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.855566e-01 | 0.105 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.855566e-01 | 0.105 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.855566e-01 | 0.105 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 7.855566e-01 | 0.105 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.862228e-01 | 0.104 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.862228e-01 | 0.104 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.862228e-01 | 0.104 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.862228e-01 | 0.104 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 7.893253e-01 | 0.103 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.904992e-01 | 0.102 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.915475e-01 | 0.102 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.973937e-01 | 0.098 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.019049e-01 | 0.096 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.020067e-01 | 0.096 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.020067e-01 | 0.096 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 8.047323e-01 | 0.094 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.055087e-01 | 0.094 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.055087e-01 | 0.094 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.055087e-01 | 0.094 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.055087e-01 | 0.094 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.055087e-01 | 0.094 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.063901e-01 | 0.093 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 8.063901e-01 | 0.093 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.063901e-01 | 0.093 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.063901e-01 | 0.093 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 8.063901e-01 | 0.093 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.063901e-01 | 0.093 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.101641e-01 | 0.091 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.128301e-01 | 0.090 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.139544e-01 | 0.089 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.173832e-01 | 0.088 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.173832e-01 | 0.088 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.173832e-01 | 0.088 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.183966e-01 | 0.087 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.183966e-01 | 0.087 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 8.232298e-01 | 0.084 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.232298e-01 | 0.084 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.232298e-01 | 0.084 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.267857e-01 | 0.083 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.293713e-01 | 0.081 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 8.293713e-01 | 0.081 | 0 | 0 |
| Utilization of Ketone Bodies | R-HSA-77108 | 8.293713e-01 | 0.081 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.293713e-01 | 0.081 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.293713e-01 | 0.081 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.293713e-01 | 0.081 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.293713e-01 | 0.081 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.293713e-01 | 0.081 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.311669e-01 | 0.080 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.317319e-01 | 0.080 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.317319e-01 | 0.080 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.332730e-01 | 0.079 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.337709e-01 | 0.079 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.379102e-01 | 0.077 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.394857e-01 | 0.076 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.394857e-01 | 0.076 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.394857e-01 | 0.076 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.431799e-01 | 0.074 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.431799e-01 | 0.074 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.431799e-01 | 0.074 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.431799e-01 | 0.074 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.434509e-01 | 0.074 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.478230e-01 | 0.072 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.480656e-01 | 0.072 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.496259e-01 | 0.071 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 8.496259e-01 | 0.071 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.496259e-01 | 0.071 | 0 | 0 |
| FMO oxidises nucleophiles | R-HSA-217271 | 8.496259e-01 | 0.071 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.496259e-01 | 0.071 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.497046e-01 | 0.071 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 8.518267e-01 | 0.070 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 8.534518e-01 | 0.069 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.543745e-01 | 0.068 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.543745e-01 | 0.068 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.543745e-01 | 0.068 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.543745e-01 | 0.068 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 8.543745e-01 | 0.068 | 0 | 0 |
| Glucocorticoid biosynthesis | R-HSA-194002 | 8.543745e-01 | 0.068 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 8.543745e-01 | 0.068 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 8.543745e-01 | 0.068 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 8.572357e-01 | 0.067 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.575363e-01 | 0.067 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.575363e-01 | 0.067 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.674772e-01 | 0.062 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.674772e-01 | 0.062 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.674772e-01 | 0.062 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 8.674772e-01 | 0.062 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.674772e-01 | 0.062 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.674772e-01 | 0.062 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.674772e-01 | 0.062 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.679916e-01 | 0.061 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.679916e-01 | 0.061 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.679916e-01 | 0.061 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.679916e-01 | 0.061 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.679916e-01 | 0.061 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.679916e-01 | 0.061 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.749703e-01 | 0.058 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.749703e-01 | 0.058 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.749703e-01 | 0.058 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.796366e-01 | 0.056 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.804291e-01 | 0.055 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 8.804291e-01 | 0.055 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.832102e-01 | 0.054 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 8.832102e-01 | 0.054 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.832102e-01 | 0.054 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.832102e-01 | 0.054 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.832102e-01 | 0.054 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.832102e-01 | 0.054 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.832102e-01 | 0.054 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.832102e-01 | 0.054 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.863436e-01 | 0.052 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.897344e-01 | 0.051 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.897344e-01 | 0.051 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.897344e-01 | 0.051 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 8.917750e-01 | 0.050 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.917750e-01 | 0.050 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.924182e-01 | 0.049 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.970763e-01 | 0.047 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.970763e-01 | 0.047 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 8.970763e-01 | 0.047 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 8.970763e-01 | 0.047 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 8.970763e-01 | 0.047 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.970763e-01 | 0.047 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.970763e-01 | 0.047 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.970763e-01 | 0.047 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.970763e-01 | 0.047 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.984903e-01 | 0.046 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.989221e-01 | 0.046 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.989221e-01 | 0.046 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 8.989221e-01 | 0.046 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.021132e-01 | 0.045 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.021132e-01 | 0.045 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.021132e-01 | 0.045 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.021132e-01 | 0.045 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.021132e-01 | 0.045 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.021132e-01 | 0.045 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.021132e-01 | 0.045 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.021132e-01 | 0.045 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.085802e-01 | 0.042 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.085802e-01 | 0.042 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 9.092967e-01 | 0.041 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.092967e-01 | 0.041 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 9.092967e-01 | 0.041 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.092967e-01 | 0.041 | 0 | 0 |
| Synthesis of 12-eicosatetraenoic acid derivatives | R-HSA-2142712 | 9.092967e-01 | 0.041 | 0 | 0 |
| Beta oxidation of butanoyl-CoA to acetyl-CoA | R-HSA-77352 | 9.092967e-01 | 0.041 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 9.092967e-01 | 0.041 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.092967e-01 | 0.041 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.092967e-01 | 0.041 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.092967e-01 | 0.041 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.092967e-01 | 0.041 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.104613e-01 | 0.041 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.108986e-01 | 0.041 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.115230e-01 | 0.040 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.115230e-01 | 0.040 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.115230e-01 | 0.040 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.200669e-01 | 0.036 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.200669e-01 | 0.036 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.200669e-01 | 0.036 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.200669e-01 | 0.036 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.200669e-01 | 0.036 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.200669e-01 | 0.036 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.200669e-01 | 0.036 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.200669e-01 | 0.036 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.200669e-01 | 0.036 | 0 | 0 |
| Mitochondrial Uncoupling | R-HSA-166187 | 9.200669e-01 | 0.036 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.200790e-01 | 0.036 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.200790e-01 | 0.036 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.200790e-01 | 0.036 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.242095e-01 | 0.034 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.278513e-01 | 0.033 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.278513e-01 | 0.033 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.278513e-01 | 0.033 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.278513e-01 | 0.033 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.291452e-01 | 0.032 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 9.291452e-01 | 0.032 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.295587e-01 | 0.032 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.295587e-01 | 0.032 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 9.295587e-01 | 0.032 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.295587e-01 | 0.032 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 9.295587e-01 | 0.032 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.295587e-01 | 0.032 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.295587e-01 | 0.032 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.295587e-01 | 0.032 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.295587e-01 | 0.032 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.297230e-01 | 0.032 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.297230e-01 | 0.032 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.311199e-01 | 0.031 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.339089e-01 | 0.030 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.339089e-01 | 0.030 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.349053e-01 | 0.029 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 9.379239e-01 | 0.028 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.379239e-01 | 0.028 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 9.379239e-01 | 0.028 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.379239e-01 | 0.028 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.409142e-01 | 0.026 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.409142e-01 | 0.026 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.413020e-01 | 0.026 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.413020e-01 | 0.026 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 9.413020e-01 | 0.026 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.414470e-01 | 0.026 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 9.452961e-01 | 0.024 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.452961e-01 | 0.024 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 9.452961e-01 | 0.024 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.452961e-01 | 0.024 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.460721e-01 | 0.024 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.460939e-01 | 0.024 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.470979e-01 | 0.024 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.470979e-01 | 0.024 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.470979e-01 | 0.024 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.494112e-01 | 0.023 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.517932e-01 | 0.021 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.517932e-01 | 0.021 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.517932e-01 | 0.021 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.525390e-01 | 0.021 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.563869e-01 | 0.019 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.570934e-01 | 0.019 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.575189e-01 | 0.019 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.575189e-01 | 0.019 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.575189e-01 | 0.019 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.575189e-01 | 0.019 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.575189e-01 | 0.019 | 0 | 0 |
| Synthesis of Ketone Bodies | R-HSA-77111 | 9.575189e-01 | 0.019 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.579971e-01 | 0.019 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.583550e-01 | 0.018 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.592060e-01 | 0.018 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.601279e-01 | 0.018 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.603978e-01 | 0.018 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.613860e-01 | 0.017 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.613860e-01 | 0.017 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.613860e-01 | 0.017 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.613860e-01 | 0.017 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.625649e-01 | 0.017 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.625649e-01 | 0.017 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.625649e-01 | 0.017 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.625649e-01 | 0.017 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.625649e-01 | 0.017 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.625649e-01 | 0.017 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.625649e-01 | 0.017 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.634212e-01 | 0.016 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.652646e-01 | 0.015 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.652646e-01 | 0.015 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.661918e-01 | 0.015 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.662815e-01 | 0.015 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.664602e-01 | 0.015 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.670118e-01 | 0.015 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.670780e-01 | 0.015 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.687668e-01 | 0.014 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.692627e-01 | 0.014 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.692775e-01 | 0.014 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 9.709306e-01 | 0.013 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.709306e-01 | 0.013 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.709306e-01 | 0.013 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.709306e-01 | 0.013 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.718451e-01 | 0.012 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.719275e-01 | 0.012 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.743842e-01 | 0.011 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.743842e-01 | 0.011 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.743842e-01 | 0.011 | 0 | 0 |
| Ketone body metabolism | R-HSA-74182 | 9.743842e-01 | 0.011 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.743842e-01 | 0.011 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.743842e-01 | 0.011 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.743842e-01 | 0.011 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.745077e-01 | 0.011 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.747782e-01 | 0.011 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.747782e-01 | 0.011 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.762841e-01 | 0.010 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.764119e-01 | 0.010 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.764119e-01 | 0.010 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.772230e-01 | 0.010 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.773480e-01 | 0.010 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.774276e-01 | 0.010 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.774276e-01 | 0.010 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.774900e-01 | 0.010 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.786186e-01 | 0.009 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.790917e-01 | 0.009 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.801095e-01 | 0.009 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.811322e-01 | 0.008 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.817486e-01 | 0.008 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.817486e-01 | 0.008 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.824730e-01 | 0.008 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.824730e-01 | 0.008 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.824730e-01 | 0.008 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.827548e-01 | 0.008 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.827548e-01 | 0.008 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.827975e-01 | 0.008 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.845557e-01 | 0.007 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.845557e-01 | 0.007 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.845557e-01 | 0.007 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.849666e-01 | 0.007 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.849666e-01 | 0.007 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.850105e-01 | 0.007 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.853143e-01 | 0.006 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.853143e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.853143e-01 | 0.006 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.860158e-01 | 0.006 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.863911e-01 | 0.006 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.868330e-01 | 0.006 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.880084e-01 | 0.005 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.880084e-01 | 0.005 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.884117e-01 | 0.005 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.885854e-01 | 0.005 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.894336e-01 | 0.005 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.895948e-01 | 0.005 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.905103e-01 | 0.004 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.917962e-01 | 0.004 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.924608e-01 | 0.003 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.927046e-01 | 0.003 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.927714e-01 | 0.003 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.936307e-01 | 0.003 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.945578e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.947483e-01 | 0.002 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.950552e-01 | 0.002 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.950552e-01 | 0.002 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.951324e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.953342e-01 | 0.002 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.956431e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.961612e-01 | 0.002 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.961612e-01 | 0.002 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.961612e-01 | 0.002 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.966177e-01 | 0.001 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.966177e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.966177e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.967110e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.967706e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.970199e-01 | 0.001 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.973743e-01 | 0.001 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.973743e-01 | 0.001 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.979618e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.982342e-01 | 0.001 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.984178e-01 | 0.001 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.984178e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.984239e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.984791e-01 | 0.001 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.985567e-01 | 0.001 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.986060e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.986060e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.986413e-01 | 0.001 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.986631e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.986631e-01 | 0.001 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.987271e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.987450e-01 | 0.001 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.987719e-01 | 0.001 | 0 | 0 |
| The canonical retinoid cycle in rods (twilight vision) | R-HSA-2453902 | 9.987719e-01 | 0.001 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.987973e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.989078e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.989790e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.990467e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.990764e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.992601e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.992601e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.992920e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.993904e-01 | 0.000 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.994257e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.994375e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.994987e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.994987e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.994987e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.995781e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.996061e-01 | 0.000 | 1 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.996541e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.996843e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.996953e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.997771e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998016e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.998090e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998145e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.998383e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.998383e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.998428e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998610e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.998895e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999000e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999085e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999227e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999335e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999450e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999484e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999498e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999540e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.999545e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999545e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999599e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999625e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999647e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.999689e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999760e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.999813e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999913e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999917e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999940e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999946e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999951e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999952e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999972e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999973e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999985e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999986e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999987e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999989e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999990e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999991e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999994e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999996e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999998e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999998e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999999e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |